Company Overview of Microbiotix, Inc.
Microbiotix, Inc., a biopharmaceutical company, engages in the research and development of small molecule anti-infective drugs for the treatment of infectious diseases. Its products include MBX-700 and MBX-701 that are irreversible non-nucleoside inhibitors of the hepatitis C virus polymerase; and MBX-400, a potent nucleoside DNA polymerase inhibitor for the treatment of human cytomegalovirus. The company also engages in the clinical research and development of antibacterial and antiviral discovery programs in the areas of filovirus, malaria, gram-negative bacterial infections, multi-drug resistant tuberculosis, and influenza. It serves its customers worldwide. Microbiotix was founded in 199...
One Innovation Drive
Worcester, MA 01605
Founded in 1998
Key Executives for Microbiotix, Inc.
Chief Operating Officer and Director
Consultant and Member of The Scientific Advisory Board
Compensation as of Fiscal Year 2014.
Microbiotix, Inc. Key Developments
Microbiotix, Inc. Presents at 12th Annual BIO Investor Forum, Oct-08-2013
Oct 4 13
Microbiotix, Inc. Presents at 12th Annual BIO Investor Forum, Oct-08-2013 . Venue: The Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.
Microbiotix, Inc. and Merck & Co. Inc. Announce Exclusive Worldwide Licensing Agreement for HCV NS5B Non-Nucleoside Polymerase Inhibitors
Jan 2 13
Microbiotix, Inc. entered into an exclusive licensing agreement with Merck & Co. Inc. As part of this agreement, Microbiotix gains worldwide rights to develop, manufacture and commercialize MBX-700 and MBX-701 (formerly SCH 900942 and SCH 900188), two non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase. MBX-700 is in Phase I clinical testing and MBX-701 is currently in preclinical development. Merck is eligible for milestone payments during development stages of the candidates, and for royalty payments from any resulting products. Specific terms of the agreement were not disclosed.
Microbiotix, Inc. Presents at BIO Asia International Conference 2013, Jan-29-2013
Dec 6 12
Microbiotix, Inc. Presents at BIO Asia International Conference 2013, Jan-29-2013 . Venue: Grand Hyatt Tokyo, 6-10-3 Roppongi, Minato-Ku, Tokyo 106-0032, Japan.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|